SV2002000442A - Metodo para regular la angiogenesis usando proteina ryk ref. msb-7266-sv - Google Patents
Metodo para regular la angiogenesis usando proteina ryk ref. msb-7266-svInfo
- Publication number
- SV2002000442A SV2002000442A SV2001000442A SV2001000442A SV2002000442A SV 2002000442 A SV2002000442 A SV 2002000442A SV 2001000442 A SV2001000442 A SV 2001000442A SV 2001000442 A SV2001000442 A SV 2001000442A SV 2002000442 A SV2002000442 A SV 2002000442A
- Authority
- SV
- El Salvador
- Prior art keywords
- ryk
- msb
- regulating angiogenesis
- association
- protein ref
- Prior art date
Links
- 230000033115 angiogenesis Effects 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000028571 Occupational disease Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000002780 macular degeneration Diseases 0.000 abstract 1
- 230000006884 regulation of angiogenesis Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
SE ENCONTRO QUE LA PROTEINA RYK TENIA UNA NOVEDOSA ACTIVIDAD EN LA REGULACION DE LA ANGIOGENESIS. SE CONSTRUYERON NUEVAS PROTEINAS RYK VARIANTES QUE SON VENTAJOSAS PARA MODULAR LA ACTIVIDAD FORMADORA DE CAPILARES DE LAS CELULAS ENDOTELIALES. LAS PROTEINAS RYK VARIANTES PUEDEN SER UTILIZADOS COMO AGENTES TERAPEUTICOS EN ENFERMEDADES TALES COMO EL CANCER, LA CICATRIZACION DE HERIDAS, LAS RETINOPATIAS DIABETICAS, LA DEGENERACION MACULAR Y LAS ENFERMEDADES CARDIOVASCULARES, ASI COMO OTRAS ENFERMEDADES O TRASTORNOS CICLICOS EN LA QUE LA ANGIOGENESIS ESTA INVOLUCRADA EN LA CAUSA O EL TRATAMIENTO DE LA ENFERMEDAD
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56878300A | 2000-05-10 | 2000-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2002000442A true SV2002000442A (es) | 2002-07-03 |
Family
ID=24272718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2001000442A SV2002000442A (es) | 2000-05-10 | 2001-05-09 | Metodo para regular la angiogenesis usando proteina ryk ref. msb-7266-sv |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1287121A2 (es) |
| JP (1) | JP2004527206A (es) |
| AR (1) | AR028424A1 (es) |
| AU (1) | AU2001261343A1 (es) |
| CA (1) | CA2408349A1 (es) |
| CO (1) | CO5300464A1 (es) |
| DO (1) | DOP2001000164A (es) |
| EC (1) | ECSP014068A (es) |
| GT (1) | GT200100079A (es) |
| PE (1) | PE20011218A1 (es) |
| SV (1) | SV2002000442A (es) |
| UY (1) | UY26696A1 (es) |
| WO (1) | WO2001085789A2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1471934A2 (en) * | 2002-02-06 | 2004-11-03 | DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung | Kinases involved in the regulation of energy homeostasis |
| JO3283B1 (ar) | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
| EA035674B1 (ru) | 2014-07-18 | 2020-07-24 | Санофи | Способ определения того, является ли пациент, предположительно страдающий от рака, кандидатом для терапии афлиберцептом |
| TW202315894A (zh) * | 2021-08-18 | 2023-04-16 | 美國加利福尼亞大學董事會 | 抗受體相關酪胺酸激酶（ｒｙｋ）抗體及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0646129A4 (en) * | 1992-05-11 | 1995-07-19 | Ludwig Inst Cancer Res | MOLECULES, WHICH ARE SIMILAR TO THE TYROSIN KINASE OF THE RECEPTOR TYPE (01/13/94). |
| AU4606196A (en) * | 1994-12-23 | 1996-07-19 | Ludwig Institute For Cancer Research | Assay, receptor proteins and ligands |
| WO1999064589A1 (en) * | 1998-06-11 | 1999-12-16 | Astrazeneca Ab | Human receptor tyrosine kinase |
| WO2000024415A2 (en) * | 1998-10-28 | 2000-05-04 | Cornell Research Foundation, Inc. | Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
-
2001
- 2001-05-07 AR ARP010102149A patent/AR028424A1/es not_active Application Discontinuation
- 2001-05-07 GT GT200100079A patent/GT200100079A/es unknown
- 2001-05-08 UY UY26696A patent/UY26696A1/es not_active Application Discontinuation
- 2001-05-09 JP JP2001582388A patent/JP2004527206A/ja active Pending
- 2001-05-09 CA CA002408349A patent/CA2408349A1/en not_active Abandoned
- 2001-05-09 EP EP01935233A patent/EP1287121A2/en not_active Withdrawn
- 2001-05-09 SV SV2001000442A patent/SV2002000442A/es not_active Application Discontinuation
- 2001-05-09 CO CO01036462A patent/CO5300464A1/es unknown
- 2001-05-09 EC EC2001004068A patent/ECSP014068A/es unknown
- 2001-05-09 AU AU2001261343A patent/AU2001261343A1/en not_active Abandoned
- 2001-05-09 WO PCT/US2001/015043 patent/WO2001085789A2/en not_active Ceased
- 2001-05-10 PE PE2001000417A patent/PE20011218A1/es not_active Application Discontinuation
- 2001-05-10 DO DO2001000164A patent/DOP2001000164A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001085789A3 (en) | 2002-05-16 |
| WO2001085789A2 (en) | 2001-11-15 |
| GT200100079A (es) | 2001-12-31 |
| JP2004527206A (ja) | 2004-09-09 |
| AU2001261343A1 (en) | 2001-11-20 |
| EP1287121A2 (en) | 2003-03-05 |
| UY26696A1 (es) | 2001-12-28 |
| PE20011218A1 (es) | 2002-02-01 |
| DOP2001000164A (es) | 2002-05-15 |
| ECSP014068A (es) | 2002-02-25 |
| CO5300464A1 (es) | 2003-07-31 |
| CA2408349A1 (en) | 2001-11-15 |
| AR028424A1 (es) | 2003-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE340581T1 (de) | Verfahren zur behandlung von prostaterkrankungen unter verwendung von vitamin-d-formulierungen mit verzögerter und/oder verlängerter wirkstofffreigabe | |
| ES2166783T3 (es) | Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii. | |
| CY1107248T1 (el) | Συντηγμενες πρωτεϊνες | |
| NO962088D0 (no) | Preparat for in vivo-produksjon av terapeutiske produkter | |
| ECSP045065A (es) | Queratinocitos utilizables como sustancia biológicamente activa en el tratamiento de heridas | |
| IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
| ES2194935T3 (es) | Preparados estables de transglutaminasa y procedimiento para su preparacion. | |
| BR0204596A (pt) | Composição tópica, e, métodos para melhorar a aparência estética da pele, para intensificar a eficácia terapêutica de uma composição tópica para a pele, unha, lábios e/ou cabelo e para intensificar a produção de um constituinte de célula de planta predeterminada | |
| ATE365550T1 (de) | Verwendung von einem protein kinase hemmer wie z.b. genistein bei der behandlung von diabetischer retinopathie | |
| MXPA02012075A (es) | Composicion para mediar el dolor y aparato y metodo para utilizarla. | |
| ES2077559T3 (es) | Estabilizacion de proteinas terapeuticamente activas en preparados farmaceuticos. | |
| BRPI0407611A (pt) | agente anti-cáncer compreendendo proteìna lk8 como um ingrediente ativo | |
| SV2002000442A (es) | Metodo para regular la angiogenesis usando proteina ryk ref. msb-7266-sv | |
| DK1343472T3 (da) | Thixotropisk næsespray | |
| ES2110057T3 (es) | Composicion medicinal que contiene tcf-ii. | |
| DE60107444D1 (de) | Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen | |
| CY1107346T1 (el) | Φαρμακευτικη συνθεση για την ενδοκυτταρια οξινιση με cis-ουροκανικο οξυ | |
| SV2002000362A (es) | Proteinas que tienen una actividad moduladora de angiogenesis ref.msb-7265-sv | |
| CO5070621A1 (es) | Metodo para incrementar el volumen oseo | |
| AR024497A1 (es) | Composiciones cosmeticas para el cuidado de la piel que contienen alcohol cumico | |
| ITTO20000441A0 (it) | Composizione terapeutica per la cura della psoriasi. | |
| DOP2001000141A (es) | Proteina actuando como un modulador angiogenico | |
| DE69821227D1 (de) | Verwendung von papovavirus kapsid-proteinen zur verabreichung therapeutischen agentien in nervzellen | |
| AR034063A1 (es) | Productos capilares y empleo de aceites naturales con tocoferoles, esteroles y/o carotenoides y de preparaciones | |
| DE60222633D1 (de) | Verwendung von matrixprotein für gesteuerte geweberegenerationen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Lapse |